IR@PKUHSC  > 北京大学第一临床医学院  > 内分泌内科
学科主题临床医学
Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs
Li, Guang-wei1; Jia, Wei-ping2; Pan, Chang-yu3; Guo, Xiao-hui4; Zou, Da-jin5
刊名DIABETES RESEARCH AND CLINICAL PRACTICE
2008-03-20
suppl.1页:S32-S33
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Endocrinology & Metabolism
研究领域[WOS]Endocrinology & Metabolism
语种英语
WOS记录号WOS:000259362500084
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63889
专题北京大学第一临床医学院_内分泌内科
作者单位1.Shanghai 6 People Hosp, Dept Endocrinol, Shanghai, Peoples R China
2.Peking Univ, Hosp 1, Dept Endocrinol, Beijing, Peoples R China
3.Peking China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
4.Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
5.Shanghai Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Li, Guang-wei,Jia, Wei-ping,Pan, Chang-yu,et al. Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs[J]. DIABETES RESEARCH AND CLINICAL PRACTICE,2008,suppl.1:S32-S33.
APA Li, Guang-wei,Jia, Wei-ping,Pan, Chang-yu,Guo, Xiao-hui,&Zou, Da-jin.(2008).Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs.DIABETES RESEARCH AND CLINICAL PRACTICE,suppl.1,S32-S33.
MLA Li, Guang-wei,et al."Efficacy and safety of repaglinide in combination with metformin in Type 2 diabetes inadequately controlled with oral anti-diabetic drugs".DIABETES RESEARCH AND CLINICAL PRACTICE suppl.1(2008):S32-S33.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Guang-wei]的文章
[Jia, Wei-ping]的文章
[Pan, Chang-yu]的文章
百度学术
百度学术中相似的文章
[Li, Guang-wei]的文章
[Jia, Wei-ping]的文章
[Pan, Chang-yu]的文章
必应学术
必应学术中相似的文章
[Li, Guang-wei]的文章
[Jia, Wei-ping]的文章
[Pan, Chang-yu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。